Health ❯Healthcare ❯Pharmaceuticals

Diabetes Treatments

GLP-1 Drugs Mounjaro Tirzepatide Ozempic GLP-1 Receptor Agonists

Eli Lilly Reports Mixed Q4 Results as Key Drug Sales Fall Short of Expectations

FDA Approves Ozempic for Chronic Kidney Disease in Type 2 Diabetes Patients

FDA Ends Shortage of Eli Lilly’s Weight-Loss Drug, Restricts Copycat Versions

Surge in GLP-1 Drugs for Weight Loss Sparks Concerns Over Diabetes Treatment